Pasithea Therapeutics Announces Positive In Vivo Preclinical Efficacy Data for PAS-004 from NRAS Mutation Cancer ... - Marketscreener.com

NVIVDelisted Stock  USD 1.38  0.07  5.34%   
Slightly above 55% of InVivo Therapeutics' sophisticated investors are presently thinking to get in. The analysis of current outlook of investing in InVivo Therapeutics Holdings suggests that some traders are interested regarding InVivo Therapeutics' prospects. InVivo Therapeutics' investing sentiment can be driven by a variety of factors including economic data, InVivo Therapeutics' earnings reports, geopolitical events, and overall market trends.
  
Pasithea Therapeutics Announces Positive In Vivo Preclinical Efficacy Data for PAS-004 from NRAS Mutation Cancer ... Marketscreener.com

Read at news.google.com
Google News at Macroaxis
  

InVivo Therapeutics Fundamental Analysis

We analyze InVivo Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of InVivo Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of InVivo Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Return On Equity

Return On Equity Comparative Analysis

InVivo Therapeutics is currently under evaluation in return on equity category among its peers. Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

InVivo Therapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with InVivo Therapeutics stock to make a market-neutral strategy. Peer analysis of InVivo Therapeutics could also be used in its relative valuation, which is a method of valuing InVivo Therapeutics by comparing valuation metrics with similar companies.

Peers

InVivo Therapeutics Related Equities

SABSSAB Biotherapeutics   5.43   
0%
44.0%
NTRBNutriband   0.98   
0%
8.0%
MOLNMolecular Partners   0.73   
0%
5.0%
ANEBAnebulo Pharmaceuticals   0.72   
0%
5.0%
ASMBAssembly Biosciences   0.20   
0%
1.0%
SNTISenti Biosciences   0.36   
2.0%
0%
CTMXCytomX Therapeutics   0.89   
7.0%
0%
NXTCNextCure   0.92   
7.0%
0%
RZLTRezolute   1.08   
8.0%
0%
VRAXVirax Biolabs   2.48   
20.0%
0%
RNXTRenovoRx   3.03   
24.0%
0%
SPROSpero Therapeutics   4.35   
35.0%
0%
LGVNLongeveron LLC   5.10   
41.0%
0%
KPRXKiora Pharmaceuticals   5.41   
44.0%
0%
HCWBHCW Biologics   7.69   
63.0%
0%
QNRXQuoin Pharmaceuticals   9.59   
78.0%
0%
REVBRevelation Biosciences   12.20   
100.0%
0%
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Consideration for investing in InVivo Stock

If you are still planning to invest in InVivo Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the InVivo Therapeutics' history and understand the potential risks before investing.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.